New approach aims to wipe out hidden cancer cells after lung surgery
Disease control
Ongoing
This study tests whether adding an immunotherapy drug (atezolizumab) to standard chemotherapy after lung cancer surgery can better prevent the cancer from returning. It focuses on patients who have signs of remaining cancer cells in their blood after surgery, which indicates high…
Phase: PHASE2 • Sponsor: Nasser Hanna • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC